Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Energy comparison of affinity to mTOR in two compounds

From: Cryptotanshinone activates AMPK-TSC2 axis leading to inhibition of mTORC1 signaling in cancer cells

Compound CDOCKER Energya CDOCKER Interaction Energya
Rapamycin −69.294 −80.192
Cryptotanshinone −0.443 −29.761
  1. aLess energy, more stable